Companies

Exscientia Plc

NASDAQ: EXAI
$4.84
▲ $0.00 (+0.00%) today
Markets closed · 6:38pm ET

About EXAI

Exscientia Plc is a pioneering pharmatech company based in Oxford, UK, leveraging artificial intelligence to revolutionize drug discovery and development. Founded in 2012, it specializes in using AI to identify new drug targets, design drug candidates, and optimize patient selection. Its innovative platform streamlines the creation of small molecule drugs, aiming to deliver effective therapies faster and more efficiently than traditional methods.

EXAI Coverage